Lilly Acquires Diabetes Candidates In Deal With Transition Therapeutics

After ending its efforts to develop inhaled insulin, Lilly rebuilds in-house pipeline of diabetes candidates.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet